The table below shows ARROWHEAD PHARMACEUTICALS, INC.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q4 2025
Q4 2024
Q4 2023
Q4 2022
Q4 2021
Q4 2020
Operating cash flow
$13.48M
-$146.27M
-$117.84M
-$75.52M
-$61.31M
-$38.92M
Capital expenditure
$2.15M
$7.52M
$68.66M
$38.91M
$5.78M
$4.27M
Investing cash flow
-$23.74M
$76.91M
$64.84M
-$80.69M
-$33.38M
$30.16M
Dividends paid
-
-
-
-
ARWR operating cash flow (10-K history)
ARROWHEAD PHARMACEUTICALS, INC. reported operating cash flow of $179.55M for fiscal year 2025. That is up 138.8% from -$462.85M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$64.43M (FY 2016) to $179.55M. Figures come from the company's audited annual reports as filed with the SEC.
